Kupffer cell pathways (KC pathways)

Kupffer cell pathways encompass the complex signaling networks within the resident macrophages of the liver sinusoids, which serve as the first line of defense against gut-derived pathogens and toxins. These pathways, including Toll-like receptor 4 (TLR4) signaling and NLRP3 inflammasome activation, are critical for maintaining hepatic homeostasis and regulating the local immune environment (Dixon et al., 2013; Krenkel & Tacke, 2017). In pathological states such as metabolic dysfunction-associated steatohepatitis (MASH) or alcoholic liver disease, Kupffer cells become chronically activated, transitioning to a pro-inflammatory M1-like phenotype that secretes cytokines like Tumor Necrosis Factor-alpha (TNF-alpha) and Interleukin-1 beta (IL-1beta). This activation triggers the recruitment of secondary immune cells and the activation of hepatic stellate cells, ultimately driving liver fibrosis and cirrhosis (Roberts et al., 2007; Tacke, 2017). While not a single molecular target, various components of these pathways are targeted by experimental therapeutics to mitigate chronic liver inflammation and prevent disease progression (Kazankov et al., 2019). Therapeutic strategies often focus on inhibiting specific receptors like CCR2/CCR5 or enzymes like ASK1 that mediate these cellular responses. Monitoring these pathways often involves measuring soluble markers of macrophage activation in the serum.

Other names

Hepatic macrophage signalingKupffer cell activationLiver macrophage pathways

Modulation of hepatic macrophage polarization and inhibition of pro-inflammatory cytokine cascades to reduce liver inflammation and fibrosis.